This meta-analysis assessed the relationship between CTNNB1 mutations and clinicopathological parameters, including metastasis, vascular invasion, tumor size, differentiation, TNM stages, liver cirrhosis, and HBV/HCV infection (Table 2). Here, CTNNB1 is linked to neoplasm.